Continuus Pharmaceuticals Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Cancelled)

  • Investors
  • 5

Continuus Pharmaceuticals General Information

Description

Developer of a novel manufacturing platform intended to reduce the cost of pharmaceuticals. The company utilizes state-of-the-art technologies to develop an integrated end-to-end continuous process to produce final drug products from raw materials, enabling companies to reduce costs and increase efficiency.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 25-R Olympia Avenue
  • Woburn, MA 01801
  • United States
+1 (781)
Primary Industry
Machinery (B2B)
Vertical(s)
Corporate Office
  • 25-R Olympia Avenue
  • Woburn, MA 01801
  • United States
+1 (781)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Continuus Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC Cancelled Generating Revenue
10. Later Stage VC 15-Feb-2023 Completed Generating Revenue
9. Later Stage VC Completed Generating Revenue
8. Debt - PPP 03-May-2020 Completed Generating Revenue
7. Later Stage VC (Series B) 26-Aug-2019 Completed Generating Revenue
6. Grant 21-Sep-2017 Completed Generating Revenue
5. Grant 01-Nov-2016 Completed Generating Revenue
4. Grant 01-Jan-2015 Completed Startup
3. Early Stage VC (Series A) 18-Jun-2014 $2.46M $2.73M Completed Startup
2. Seed Round 21-May-2013 $265K $265K Completed Startup
To view Continuus Pharmaceuticals’s complete valuation and funding history, request access »

Continuus Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Continuus Pharmaceuticals’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Continuus Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a novel manufacturing platform intended to reduce the cost of pharmaceuticals. The company utilizes state-o
Machinery (B2B)
Woburn, MA
21 As of 2023

Dusseldorf, Germany
 

Breda, Netherlands
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Continuus Pharmaceuticals Competitors (4)

One of Continuus Pharmaceuticals’s 4 competitors is GEA Group, a Formerly PE-Backed company based in Dusseldorf, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GEA Group Formerly PE-Backed Dusseldorf, Germany
Repligen Europe Corporation Breda, Netherlands
On Demand Pharmaceuticals Angel-Backed Rockville, MD
Phlow Venture Capital-Backed Richmond, VA
To view Continuus Pharmaceuticals’s complete competitors history, request access »

Continuus Pharmaceuticals Patents

Continuus Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026030217-A2 Continuous stirred tank reactors, arrays thereof, and methods of use Pending 29-Jul-2024
WO-2026030217-A3 Continuous stirred tank reactors, arrays thereof, and methods of use Pending 29-Jul-2024
CA-3100548-A1 System for molding and coating of pharmaceutical tablets Pending 11-Jun-2018
EP-3801493-A1 System for molding and coating of pharmaceutical tablets Active 11-Jun-2018
EP-3801493-A4 System for molding and coating of pharmaceutical tablets Active 11-Jun-2018 A61J3/005
To view Continuus Pharmaceuticals’s complete patent history, request access »

Continuus Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Continuus Pharmaceuticals Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
US National Science Foundation Accelerator/Incubator
Industria Macchine Automatiche PE-Backed Company Minority
MassChallenge Accelerator/Incubator
Pimlico Pond Investments Family Office Minority
To view Continuus Pharmaceuticals’s complete investors history, request access »

Continuus Pharmaceuticals FAQs

  • When was Continuus Pharmaceuticals founded?

    Continuus Pharmaceuticals was founded in 2012.

  • Where is Continuus Pharmaceuticals headquartered?

    Continuus Pharmaceuticals is headquartered in Woburn, MA.

  • What is the size of Continuus Pharmaceuticals?

    Continuus Pharmaceuticals has 21 total employees.

  • What industry is Continuus Pharmaceuticals in?

    Continuus Pharmaceuticals’s primary industry is Machinery (B2B).

  • Is Continuus Pharmaceuticals a private or public company?

    Continuus Pharmaceuticals is a Private company.

  • What is Continuus Pharmaceuticals’s current revenue?

    The current revenue for Continuus Pharmaceuticals is .

  • How much funding has Continuus Pharmaceuticals raised over time?

    Continuus Pharmaceuticals has raised $24.7M.

  • Who are Continuus Pharmaceuticals’s investors?

    , US National Science Foundation, Industria Macchine Automatiche, MassChallenge, and Pimlico Pond Investments have invested in Continuus Pharmaceuticals.

  • Who are Continuus Pharmaceuticals’s competitors?

    GEA Group, Repligen Europe, On Demand Pharmaceuticals, and Phlow are competitors of Continuus Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process